Theory · 1845–1990
The biological turn
From Griesinger's claim in the 1840s that mental illness is brain disease, through the microscope, the shock therapies and the drug revolution, to DSM-III in 1980: how psychiatry repeatedly turned to the body.
In 1868, the last year of his life, the Berlin professor Wilhelm Griesinger launched a new journal, the Archiv für Psychiatrie und Nervenkrankheiten. Its programme announced that psychiatry had been transformed: patients with so-called mental illnesses, it said, were really people with illnesses of the nerves and the brain7. The slogan usually attached to his name, "mental diseases are brain diseases", compressed a programme that would recur in psychiatry for the next century and a half. Each time it returned it brought new tools, the microscope, the laboratory, the drug trial, the scanner, and each time it promised more than it delivered, while delivering some things of lasting value.
Griesinger and the first biological psychiatry
Griesinger's textbook, first published in 1845 and revised in 1861, opened by asking which organ "must necessarily and invariably be diseased where there is madness"1. His answer was unhesitating:
Physiological and pathological facts show us that this organ can only be the brain; we therefore primarily, and in every case of mental disease, recognise a morbid action of that organ.1
Quotation checked against the 1867 text
Griesinger was no crude materialist; he also argued for short stays in hospital and close cooperation with patients' families and communities7. But he urged psychiatrists to make the autopsy their principal research method, and his pupils, among them Carl Westphal, Theodor Meynert and Carl Wernicke, became the first generation of academic psychiatrists, working in university clinics and laboratories rather than in the great rural asylums2. Meynert, professor in Vienna from 1873, built elaborate maps of fibre tracts and explained mental symptoms by imagined disturbances of the brain's blood supply and nervous excitation2.
The young Emil Kraepelin was unconvinced. In his inaugural lecture at Dorpat in 1887 he warned against moving into "Meynert's airily-constructed house" before its foundations were laid, and turned instead to the careful description of the course of illness that produced dementia praecox and manic-depressive insanity2. In 1913 the psychiatrist-philosopher Karl Jaspers gave the speculative anatomy of Meynert's school a name that stuck: "brain mythology"2.
What the microscope found
Neuropathology nevertheless had real triumphs. In November 1901 Alois Alzheimer, then at the Frankfurt asylum, first examined a woman with an unusual early dementia, known in the literature as Auguste D. After her death in 1906 he studied her brain in Kraepelin's new laboratory in Munich, described the changes in it, and presented the case at a meeting of south-west German psychiatrists at Tübingen in November 1906; in the 1910 edition of his textbook Kraepelin named the condition Alzheimer's disease3. In 1913 Hideyo Noguchi and J. W. Moore at the Rockefeller Institute in New York demonstrated the organism of syphilis in the brains of patients who had died of general paralysis4. A major mental illness had a known physical cause.
The great functional psychoses did not yield in the same way. Kraepelin was sure that dementia praecox was a bodily disease, but on its cause he could offer only a cautious guess, while admitting that "all serviceable foundations are still lacking"9:
a series of facts in dementia praecox up to a certain degree makes probable the existence of an auto-intoxication in consequence of a disorder of metabolism.9
Quotation checked against the 1919 text
Neither he nor his successors found a consistent cause2,6. Researchers turned to heredity instead: from 1916 Ernst Rüdin and his colleagues in Munich studied the families of patients, and from the 1930s twin studies by Franz Kallmann and others became the main evidence for a genetic contribution to schizophrenia, a line of research entangled with eugenics and psychiatry6.
The physical treatments
Between the wars the conviction that madness was physical produced a series of bold treatments. Julius Wagner-Jauregg's malaria therapy for general paralysis (1917) won the Nobel Prize in 1927. It was followed by Manfred Sakel's insulin coma in the early 1930s, Ladislas Meduna's chemically induced convulsions in 1934, Egas Moniz's first leucotomies in 1935 and Ugo Cerletti and Lucio Bini's electroconvulsive therapy in 193810. Each rested on a theory of what it did to the brain; Meduna's, for example, assumed wrongly that epilepsy and schizophrenia could not coexist10. Most of the theories proved wrong, and of the treatments only ECT survived, in modified form.
The drug era
The decisive change came from pharmacology, largely by accident. Chlorpromazine, synthesised in December 1950 by the French company Rhône-Poulenc during a search for new antihistamines, was taken up by the surgeon Henri Laborit as a calming agent; in 1952 Jean Delay and Pierre Deniker at the Sainte-Anne hospital in Paris reported its effects on 38 psychotic patients8. Lithium for mania had been reported by John Cade in Australia in 1949, and the first antidepressants, iproniazid and imipramine, came into use in 1957–588. In the early 1960s researchers mapped the brain cells and pathways that use the chemical messengers dopamine, noradrenaline and serotonin, and theories of mental illness as a deficit or excess of these substances followed, reasoning backwards from what the new drugs appeared to do2. Chlorpromazine and its successors also changed the asylums, helping to make possible the large-scale discharge of patients described under deinstitutionalisation.
DSM-III and the "Decade of the Brain"
In the United States, where psychoanalysis had dominated psychiatry since the 1940s, the 1970s brought a reaction. Research psychiatrists, sometimes called the neo-Kraepelinians, argued for diagnoses defined by observable symptoms that different doctors could apply reliably; research funders and insurers wanted the same; and the new drug trials needed clearly defined patient groups5. The result was DSM-III (1980), which replaced psychodynamic categories with explicit criteria and was tested in field trials between 1977 and 19795. It said little about causes, but it fitted a profession that increasingly saw itself as a branch of medicine. In 1990 the United States government designated the coming years the "Decade of the Brain"8.
Key dates
- 1845 Wilhelm Griesinger publishes his textbook of mental pathology; the second edition follows in 1861.
- 1868 Griesinger's new journal, the Archiv für Psychiatrie und Nervenkrankheiten, declares that so-called mental illnesses are illnesses of the nerves and brain.
- November 1906 Alois Alzheimer describes the brain of his patient Auguste D. at a meeting of psychiatrists in Tübingen; his paper appears in 1907.
- 1913 Hideyo Noguchi and J. W. Moore find the syphilis organism in the brains of patients with general paralysis.
- 1952 Jean Delay and Pierre Deniker report treating psychotic patients with chlorpromazine at Sainte-Anne in Paris.
- 1980 DSM-III adopts descriptive diagnostic criteria and drops 'neurosis' as an organising concept.
- January 1990 The United States proclaims the 1990s the 'Decade of the Brain'.
Sources
- Primary source Wilhelm Griesinger, Mental Pathology and Therapeutics (trans. C. Lockhart Robertson and James Rutherford), London: New Sydenham Society (1867). Quotations checked against this text.
- Scholarship Kenneth S. Kendler, A history of metaphorical brain talk in psychiatry, Molecular Psychiatry (2025).
- Scholarship Ricardo Nitrini, The past, present and future of Alzheimer's disease, part 1: the past, Arquivos de Neuro-Psiquiatria 81(12) (2023).
- Primary source Hideyo Noguchi and J. W. Moore, A demonstration of Treponema pallidum in the brain in cases of general paralysis, Journal of Experimental Medicine 17(2): 232–238 (1913).
- Scholarship Shadia Kawa and James Giordano, A brief historicity of the Diagnostic and Statistical Manual of Mental Disorders, Philosophy, Ethics, and Humanities in Medicine 7: 2 (2012).
- Scholarship Sarah Chaney, Sarah Marks and Rebecca Wynter, 'Almost nothing is firmly established': a history of heredity and genetics in mental health science, Wellcome Open Research 9: 23 (2024).
- Wikipedia Wilhelm Griesinger, Wikipedia (2026).
- Wikipedia Chlorpromazine; Imipramine; Iproniazid; John Cade; Decade of the Brain, Wikipedia (2026).
- Primary source Emil Kraepelin (trans. R. Mary Barclay), Dementia Praecox and Paraphrenia, Edinburgh: E. and S. Livingstone (1919). Quotations checked against this text.
- Wikipedia Julius Wagner-Jauregg; Insulin shock therapy; Convulsive therapy; Electroconvulsive therapy; Lobotomy, Wikipedia (2026).
Cross-checked with Wikidata Q2706176 and the English Wikipedia article.
Pages that mention The biological turn
- Diagnosis Dementia praecox
- Diagnosis General paralysis of the insane
- Essay "On being sane in insane places": Rosenhan's study and its challengers
- Person Egas Moniz
- Person Emil Kraepelin
- Person John Cade
- Person Julius Wagner-Jauregg
- Person Sigmund Freud
- Person Ugo Cerletti
- Person Walter Freeman
- Place The Burghölzli, Zurich
- Theory Degeneration theory
- Theory Eugenics and psychiatry
- Theory Phrenology
- Theory Psychoanalysis
- Treatment Chlorpromazine
- Treatment Electroconvulsive therapy, then and now
- Treatment Insulin coma therapy
- Treatment Lithium
- Treatment Lobotomy
- Treatment Malaria therapy
- Treatment Metrazol convulsive therapy
- Treatment The first antidepressants